Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Bo Cumbo has nearly three decades of pharmaceutical and biotechnology industry experience, including commercial launches of 11 specialty or rare disease drugs. He is currently president, chief executive officer and board member of Solid Biosciences. Previously, Bo served as president and chief executive officer of AavantiBio, Inc. Prior to AavantiBio, he held leadership positions at Sarepta Therapeutics, Inc., most recently as the executive vice president and chief commercial officer. Previously, Bo served as vice president of sales, key account management, and treatment educator teams at Vertex Pharmaceuticals. Earlier in his career, he served in multiple commercial roles supporting the HIV, HBV, and cardiovascular franchises at Gilead Sciences.
Bo holds a B.S. in Laboratory Technology from Auburn University.
Meet the rest of our
see all team members
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
Troy Lister, Ph.D.
Senior Vice President, Research and Early Development
Sheila Mikhail, J.D.
Co-Founder and Former Chief Executive Officer, AskBio; Co-Founder and Chief Executive Officer, Jurata Thin Film
Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Allison Dorval
Chief Financial Officer
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Joan Nickerson
Chief Administrative Officer
Penny M. Heaton, M.D.
Global Therapeutic Area Head, Infectious Diseases & Vaccines, Janssen Research & Development
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Jason Politi
Chief Technical Operations Officer
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Issi Rozen
Venture Partner, GV
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Fred Fiedorek, M.D.
Chief Medical Officer
